Withdrawals of PROCTOLOG rectal cream and PROCTOLOG Suppositories on 6 july 2017 in the market. Prescription strictly prohibited

PROCTOLOG 5,8 %/0,5 % rectal cream tube 20 g and PROCTOLOG 120 mg/10 mg Suppositories 

  PROCTOLOG rectal cream and  PROCTOLOG  Suppositories were intended in the symptomatic treatment of painful and pruritic manifestations (fissuraires syndromes, especially the haemorrhoidal crisis. the establishment of the risk / benefit ratio proved to be negative. Approved in the market since  2005, to date it is  noted that on 6 july 2017 these drugs are strictly prohibited to be prescribed by doctor to their patients. 

http://ansm.fr